Literature DB >> 4199745

Significance of Pseudomonas aeruginosa in sputum.

M W Burns.   

Abstract

Pseudomonas aeruginosa was isolated from the sputum of 63 patients. In 34 the organism was a commensal, in 14 it was causing chronic suppuration, and in 10 had interfered with antibiotics directed against other organisms and was thus indirectly pathogenic. In five patients, all of whom died, the organism could have been acting as an acute pathogen. Attempts should be made to determine the nature of the organism's pathogenicity in a given patient and appropriate therapy withheld or administered accordingly.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4199745      PMCID: PMC1586668          DOI: 10.1136/bmj.3.5876.382

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  TOXICITY OF PSEUDOMONAS AERUGINOSA SLIME.

Authors:  W S CALLAHAN; B BEYERLEIN; J D MULL
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

2.  Cross-infection with Pseudomonas pyocyanea.

Authors:  R WILLIAMS; E D WILLIAMS; D E HYAMS
Journal:  Lancet       Date:  1960-02-13       Impact factor: 79.321

3.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

4.  Occurrence of serious bacterial infections since introduction of antibacterial agents.

Authors:  M FINLAND; W F JONES; M W BARNES
Journal:  J Am Med Assoc       Date:  1959-08-29

5.  Dose of gentamicin in patients with normal renal function and renal impairment.

Authors:  J C Gingell; P M Waterworth
Journal:  Br Med J       Date:  1968-04-06

6.  Pseudomonas aeruginosa--its characterization and identification.

Authors:  W C HAYNES
Journal:  J Gen Microbiol       Date:  1951-11

7.  "Indirect pathogenicity" of penicillinase-producing enterobacteria in chronic bronchial infections.

Authors:  J L Maddocks; J R May
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

8.  The significance of various bacteria in chronic bronchial disorders as determined by bacterial antibody detection.

Authors:  M W Burns
Journal:  Australas Ann Med       Date:  1968-11

9.  Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.

Authors:  R A Shooter; K A Walker; V R Williams; G M Horgan; M T Parker; E H Asheshov; J F Bullimore
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

10.  ENZYMATIC ACTION ON THE CAPSULAR MATERIAL PRODUCED BY PSEUDOMONAS AERUGINOSA OF CYSTIC FIBROSIS ORIGIN.

Authors:  R G DOGGETT; G M HARRISON; R N STILLWELL; E S WALLIS
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

View more
  3 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis.

Authors:  S W Hla; K P Hui; W C Tan; B Ho
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera.

Authors:  T L Pitt; H C Todd; C A Mackintosh; S W Im
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.